Two scientists won the Nobel Prize in physiology or medicine on Monday for their discovery of microRNA, tiny bits of genetic ...

Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...

American scientists Victor Ambros and Gary Ruvkun have been awarded the prestigious Nobel Prize in Physiology or ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...

The authorization is for use in individuals 12 years of age and older. In August, the U.S. Food and Drug Administration ...

Analysis - Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the ...

Victor Ambros and Gary Ruvkun are awarded the Nobel Prize in medicine for discovering microRNA, a genetic switch that can ...

Researchers at the University of Sheffield have been awarded funding for their infectious disease technology that could make ...

University of Sheffield researchers have been awarded funding to develop a new vaccine manufacturing process that could speed ...

“It might start becoming the top circulating lineage,” Rajnaranayam said, predicting XEC will take the rest of October and ...

Scholar Rock yesterday reported that its experimental treatment for spinal muscular atrophy succeeded in a Phase 3 trial, ...

Initially mistaken for neutrophils, a population of atypical macrophages appears in the lungs after severe viral infection, ...